Comparative marker analysis identifying the phosphatases most significantly associated with each group clearly identified SHP2 as an important marker of the classical subgroup of GBM and remained a significant marker even when considered alongside kinases or the whole genome. This evidence concerns the gene PTPN11 and glioblastoma.